RTX CorpRTX
RTX
About: RTX is an aerospace and defense manufacturer formed from the merger of United Technologies and Raytheon, with roughly equal exposure as a supplier to commercial aerospace and to the defense market across three segments: Collins Aerospace, a diversified aerospace supplier; Pratt & Whitney, a commercial and military aircraft engine manufacturer; and Raytheon, a defense prime contractor providing a mix of missiles, missile defense systems, sensors, hardware, and communications technology to the military.
Employees: 186,000
0
Funds holding %
of 7,425 funds
0
Analysts bullish %
of 7 analysts
Fund manager confidence
Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)
101% more first-time investments, than exits
New positions opened: 299 | Existing positions closed: 149
17% more call options, than puts
Call options by funds: $2.09B | Put options by funds: $1.79B
4% more funds holding
Funds holding: 2,668 [Q3] → 2,762 (+94) [Q4]
1.21% more ownership
Funds ownership: 79.86% [Q3] → 81.07% (+1.21%) [Q4]
9% more repeat investments, than reductions
Existing positions increased: 1,091 | Existing positions reduced: 999
1% less capital invested
Capital invested by funds: $128B [Q3] → $127B (-$1.45B) [Q4]
9% less funds holding in top 10
Funds holding in top 10: 58 [Q3] → 53 (-5) [Q4]
Research analyst outlook
7 Wall Street Analysts provided 1 year price targets over the past 3 months
Low target
$138
9%
upside
Avg. target
$145
15%
upside
High target
$160
27%
upside
7 analyst ratings
7 positive
100%
0 neutral
0%
0 negative
0%
JP Morgan Seth Seifman 59% 1-year accuracy 20 / 34 met price target | 15%upside $145 | Overweight Maintained | 28 Apr 2025 |
RBC Capital Ken Herbert 57% 1-year accuracy 38 / 67 met price target | 11%upside $140 | Outperform Maintained | 23 Apr 2025 |
Susquehanna Charles Minervino 44% 1-year accuracy 29 / 66 met price target | 11%upside $140 | Positive Maintained | 23 Apr 2025 |
UBS Gavin Parsons 60% 1-year accuracy 15 / 25 met price target | 9%upside $138 | Buy Maintained | 23 Apr 2025 |
Wells Fargo Matthew Akers 58% 1-year accuracy 47 / 81 met price target | 14%upside $144 | Overweight Maintained | 15 Apr 2025 |
Financial journalist opinion
Based on 75 articles about RTX published over the past 30 days
Positive
Reuters
9 hours ago
Trump says IBM and Raytheon might get contract to modernize air traffic controller system
President Donald Trump said on Wednesday that the companies Raytheon Technologies and IBM may get the contract to modernize the nation's air traffic controller system.
Positive
Zacks Investment Research
1 day ago
Is Trending Stock RTX Corporation (RTX) a Buy Now?
RTX (RTX) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Negative
Zacks Investment Research
2 days ago
Should You Buy, Hold or Sell RTX Stock Post Q1 Earnings Release?
Investors interested in RTX stock should avoid adding it to their portfolio, considering its premium valuation and downward revision in earnings estimates.
Positive
Seeking Alpha
5 days ago
Blue Light Special - 2 Dividend Growth Gems We're Buying With Both Hands
Volatility is flashing a Blue Light Special in markets. Fear is high, but history says these moments often reward long-term investors the most. I see this uncertainty as an opportunity. When panic strikes, I lean into quality. Two dividend growth stocks just handed us compelling entry points. These aren't random buys. They're high-conviction investments I've followed for years, now trading at discounts I believe won't last long.
Negative
MarketBeat
5 days ago
Uncertainty for Defense Stocks Creates Opportunity for Investors
Defense stocks are pulling back following Q1 reports from Lockheed Martin NYSE: LMT, Northrop Grumman NYSE: NOC, and RTX NYSE: RTX. The primary cause is uncertainty, followed by tepid guidance.
Neutral
Business Wire
6 days ago
Ray Therapeutics Awarded $8M CIRM Grant to Advance RTx-015 Gene Therapy for Retinitis Pigmentosa
BERKELEY, Calif.--(BUSINESS WIRE)--Ray Therapeutics Awarded $8M CIRM Grant to Advance RTx-015 Gene Therapy for Retinitis Pigmentosa.
Positive
Seeking Alpha
1 week ago
RTX Corporation Q1: This Business Can Tackle Tariffs Head-On And Thrive
RTX Corporation delivered a strong Q1: sales up 5% YoY ($20.3B), EPS rose 10% ($1.47), FCF at $792M; backlog secure at $217B (Commercial: $125B, Defense: $92B), ensuring revenue visibility. Tariffs could hit 2025 pretax profits by ~$850M (7-8% of operating profit); RTX proactively invested $2B in U.S. manufacturing, optimizing supply chain flexibility and pricing strategies to mitigate risk. Current valuation fair (forward non-GAAP P/E: 18.5 vs. 5-yr avg. of 20), RSI at 47.5; 12-month PT of $135 implies ~15% total return, providing geopolitical hedge amid tariff uncertainties.
Positive
Seeking Alpha
1 week ago
RTX Stock Still A Buy After Tariff Sell-Off
RTX's Q1 sales grew 8% organically to $20.3 billion, beating analyst expectations with adjusted EPS up 10% to $1.47. Despite strong results, RTX's stock fell 10% due to tariff impacts, with an estimated $850 million hit to operating profit for the year. RTX maintained its guidance, projecting $83-$84 billion in sales and $6-$6.15 EPS, but investors are disappointed by the lack of upward revision.
Positive
Zacks Investment Research
1 week ago
RTX vs. Lockheed Martin: Which Defense Stock to Consider in 2025?
Investors may stay invested in RTX due to balanced exposure across segments. Lockheed could be more appealing to those seeking attractive valuation.
Positive
Zacks Investment Research
1 week ago
Here's Why RTX (RTX) is a Strong Value Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Charts implemented using Lightweight Charts™